Subtopic Deep Dive

Echinacea Alkylamides Pharmacology
Research Guide

What is Echinacea Alkylamides Pharmacology?

Echinacea alkylamides pharmacology studies the pharmacological properties, bioavailability, mechanisms of action, and immune-modulating effects of N-alkylamides extracted from Echinacea species.

Alkylamides are lipophilic constituents in Echinacea angustifolia, pallida, and purpurea, interacting with cannabinoid receptors and stimulating phagocytosis (Woelkart and Bauer, 2007; 120 citations). Key reviews document their chemistry, occurrence, and functionality across plant species (Boonen et al., 2012; 150 citations). Over 1,000 papers explore Echinacea pharmacology, with alkylamides central to standardization efforts (Barnes et al., 2005; 414 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

Alkylamides drive Echinacea's immune effects, enabling standardized extracts for cold prevention and validated herbal therapies (Woelkart and Bauer, 2007). Gurley et al. (2012; 155 citations) highlight herb-drug interactions, guiding safe co-administration with pharmaceuticals. Caesar and Cech (2019; 730 citations) reveal synergy in extracts, improving product efficacy. Boonen et al. (2012) database supports quality control, essential for clinical trials and regulatory approval.

Key Research Challenges

Bioavailability Variability

Alkylamides exhibit low oral bioavailability due to rapid metabolism, complicating dosing (Woelkart and Bauer, 2007). Species differences in alkylamide profiles affect consistency (Barnes et al., 2005). Standardization requires precise quantification methods (Boonen et al., 2012).

Receptor Interaction Mechanisms

Interactions with CB2 cannabinoid receptors need clarification for immune signaling (Woelkart and Bauer, 2007). Synergistic effects with other constituents challenge isolation studies (Caesar and Cech, 2019). Molecular assays are limited for complex mixtures (Boonen et al., 2012).

Herb-Drug Interaction Risks

Potential pharmacokinetic interactions with CYP enzymes require assessment (Gurley et al., 2012). Clinical relevance varies by dosage and extract type (Wills et al., 2000). Long-term safety data for alkylamide-rich supplements is insufficient.

Essential Papers

1.

Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2

Lindsay K. Caesar, Nadja B. Cech · 2019 · Natural Product Reports · 730 citations

This report documents the cellular, molecular, and analytical methods used to identify combination effects in complex natural product mixtures.

2.

<i>Echinacea</i> species (<i>Echinacea angustifolia</i> (DC.) Hell., <i>Echinacea pallida</i> (Nutt.) Nutt., <i>Echinacea purpurea</i> (L.) Moench): a review of their chemistry, pharmacology and clinical properties

Joanne Barnes, Linda A. Anderson, Simon Gibbons et al. · 2005 · Journal of Pharmacy and Pharmacology · 414 citations

Abstract This paper reviews the chemistry, pharmacology and clinical properties of Echinacea species used medicinally. The Echinacea species Echinacea angustifolia, Echinacea pallida and Echinacea ...

3.

Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea

Michele Catanzaro, Emanuela Corsini, Michela Rosini et al. · 2018 · Molecules · 250 citations

The immune system is an efficient integrated network of cellular elements and chemicals developed to preserve the integrity of the organism against external insults and its correct functioning and ...

4.

Herbal products: active constituents, modes of action and quality control

R. B. H. Wills, Kerry Bone, Michelle Morgan · 2000 · Nutrition Research Reviews · 161 citations

Abstract An overview is given of the current position of medicinal herbs in general in relation to usage, market and production, types of pharmacological activity and how they differ from conventio...

5.

Pharmacokinetic Herb-Drug Interactions (Part 2): Drug Interactions Involving Popular Botanical Dietary Supplements and Their Clinical Relevance

Bill J. Gurley, E. Kim Fifer, Zöe Gardner · 2012 · Planta Medica · 155 citations

In Part 2 of this review, a critical examination of the pertinent scientific literature is undertaken in order to assess the interaction risk that popular dietary supplements may pose when taken co...

6.

Alkamid database: Chemistry, occurrence and functionality of plant N-alkylamides

Jente Boonen, Antoon Bronselaer, Joachim Nielandt et al. · 2012 · Journal of Ethnopharmacology · 150 citations

7.

The Role of Alkamides as an Active Principle of <i>Echinacea</i>

K Woelkart, Rudolf Bauer · 2007 · Planta Medica · 120 citations

Alkamides are the major lipophilic constituents of ECHINACEA preparations, which are widely used in some European countries and in North America for common colds. In earlier investigations they hav...

Reading Guide

Foundational Papers

Start with Barnes et al. (2005; 414 citations) for comprehensive chemistry and pharmacology overview, then Woelkart and Bauer (2007; 120 citations) for alkamide-specific mechanisms, and Boonen et al. (2012; 150 citations) for chemical database.

Recent Advances

Study Caesar and Cech (2019; 730 citations) on synergy effects and Gurley et al. (2012; 155 citations) on interactions for current applications.

Core Methods

Core techniques: phagocytosis stimulation assays (Woelkart and Bauer, 2007), LC-MS for profiling (Boonen et al., 2012), and interaction studies via CYP inhibition (Gurley et al., 2012).

How PapersFlow Helps You Research Echinacea Alkylamides Pharmacology

Discover & Search

Research Agent uses searchPapers for 'Echinacea alkylamides CB2 receptors' yielding Woelkart and Bauer (2007), then citationGraph maps 120 citing papers on phagocytosis. exaSearch uncovers unpublished preprints; findSimilarPapers links to Boonen et al. (2012) database for 150+ citations on N-alkylamides.

Analyze & Verify

Analysis Agent applies readPaperContent to extract bioavailability data from Gurley et al. (2012), verifies claims via CoVe against Barnes et al. (2005), and runs PythonAnalysis on dosage-response curves with NumPy for statistical verification (p<0.05). GRADE grading scores evidence as moderate for immune modulation.

Synthesize & Write

Synthesis Agent detects gaps in alkylamide synergy studies (Caesar and Cech, 2019), flags contradictions in receptor binding. Writing Agent uses latexEditText for methods sections, latexSyncCitations for 414 Barnes et al. refs, latexCompile for full review, and exportMermaid for signaling pathway diagrams.

Use Cases

"Plot alkylamide concentration vs phagocytosis from Echinacea papers"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on extracted data from Woelkart 2007) → IC50 curve plot and stats output.

"Draft LaTeX review on Echinacea alkylamide standardization"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Barnes 2005, Boonen 2012) → latexCompile → PDF with cited figures.

"Find GitHub code for alkylamide HPLC analysis"

Research Agent → paperExtractUrls (Boonen 2012) → Code Discovery → paperFindGithubRepo → githubRepoInspect → validated chromatography scripts.

Automated Workflows

Deep Research workflow scans 50+ papers via citationGraph from Woelkart and Bauer (2007), generating structured report on mechanisms with GRADE scores. DeepScan applies 7-step CoVe to verify bioavailability claims in Gurley et al. (2012). Theorizer builds hypothesis on alkylamide-CB2 synergy from Caesar and Cech (2019) extracts.

Frequently Asked Questions

What defines Echinacea alkylamides?

N-alkylamides are lipophilic compounds in Echinacea angustifolia, pallida, and purpurea, acting as major active principles (Woelkart and Bauer, 2007; Boonen et al., 2012).

What are key methods in alkylamide research?

Phagocytosis assays, cannabinoid receptor binding, and HPLC quantification assess activity and content (Woelkart and Bauer, 2007; Barnes et al., 2005).

What are seminal papers?

Barnes et al. (2005; 414 citations) reviews chemistry/pharmacology; Woelkart and Bauer (2007; 120 citations) details alkamides' immune role; Boonen et al. (2012; 150 citations) catalogs structures.

What open problems exist?

Unresolved issues include oral bioavailability optimization, full herb-drug interaction profiles, and synergy quantification in extracts (Gurley et al., 2012; Caesar and Cech, 2019).

Research Herbal Medicine Research Studies with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Echinacea Alkylamides Pharmacology with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers